Successful testing of Covid-19 vaccine discovered in US, capable of fighting the virus
There is a war against Coronavirus all over the world including India and more than 1 million people are infected with it, while more than 50 thousand people have been killed so far. Steps like lockdown are being taken in most of the countries of the world and the entire business has collapsed. In such a situation, a good news has come from American scientists. They have succeeded in testing potential viruses on mice.
Co-senior author Andrea Gambotto of the University of Pittsburgh's School of Medicine in the US claimed that we have SARS-2 in 2003 and MERS in 2014. Taking advantage of this, what we have discovered is that vaccine can prevent the infection of coronavirus strongly.
The complete information of the study on this has been published in the research journal e-Biomedicine. Researchers say their discovered vaccine is capable of producing sufficient amounts of antibodies to fight covid-19. Scientists have claimed that it will be able to neutralize the virus within two weeks of injecting the vaccine. Researchers have sought permission from the American Food and Drug Administration (FDA) for human testing after the test results showed encouraging results on mice.
Effective to neutralize virus for a year
Coronavirus is very similar to viruses called SARS and MARS. Scientists warn, since animals have not been tracked for very long, it is too early to say how much the immune system can fight coronaviruses. But this vaccine has proved unmatched on mice. It produced so many antibodies that it was able to neutralize the virus for at least a year.
Vaccine Name Pitkovac
The researchers reported that two viruses (SARS and Mars) closely associated with Kovid-19 taught us about the spike protein that is important in generating immunity against the virus. This vaccine has been named Pitkovac by these researchers. It increases immunity by forming in laboratory pieces of viral protein as in the flu.
This is how it is used
Researchers used the new drug-giving technique to increase its effectiveness. They made a patch of 400 very fine needles equal to the tip of the finger that injects pieces of spike protein into the skin, where the resistance is strongest. This patch sticks like a plaster and the needles get inside the skin, which is made up of sugar and protein.
Don't even hurt
The dermatologist Professor Lewis Fallow, who was involved in the research, said, "We adopted the same starch method used to apply small pox vaccines." But it is a high tech version which is more effective and can be made from other patients and it does not have any pain. Researchers said that this vaccine can be made on a large scale.